Skip to content
Tuesday, October 27, 2026 · Today’s edition, 6:30 a.m. ETTue, Oct 27 · 6:30 a.m. editionSign inMy Desk 0EditionsSign in

Who holds ORKAOruka Therapeutics

11 funds on our shelf carry Oruka Therapeutics — heaviest hand: XBI at 1.37% of its book.

FundWeightFund assetsShares held
XBIState Street SPDR S&P Biotech ETFINDEX1.37%$10.3B1,549,262
DWASInvesco Dorsey Wright SmallCap Momentum ETFINDEX1.25%$411M60,147
IBBQInvesco Nasdaq Biotechnology ETFINDEX0.35%$112M5,065
IBBiShares Biotechnology ETFINDEX0.34%$10.6B447,573
IWOiShares Russell 2000 Growth ETFINDEX0.28%$14.4B470,701
VTWGVanguard Russell 2000 Growth ETFINDEX0.27%$1B54,864
VFMOVanguard U.S. Momentum Factor ETFINDEX0.17%$646M39,118
VTWOVanguard Russell 2000 ETFINDEX0.14%$9.9B292,775
RSSLGlobal X Russell 2000 ETFINDEX0.14%$1.5B23,898
IWMiShares Russell 2000 ETFINDEX0.14%$74.2B1,266,050
VHTVanguard Health Care Index FundINDEX0.04%$19B117,070

LATEST DISCLOSED BOOKS ON THE ENRICHED SHELF · THE SHELF GROWS NIGHTLY AS READERS RESEARCH NEW FUNDS

ETF Dailyfrom Private Wealth Daily

ETF launches, fund research, and market coverage in your inbox every morning. Free.

Free. Every morning. Unsubscribe from any edition in one click.